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Copper binding and redox chemistry of the Ab16
peptide and its variants: insights into determinants
of copper-dependent reactivity†
Nineveh Yako, Tessa R. Young, Jade M. Cottam Jones, Craig A. Hutton,
Anthony G. Wedd and Zhiguang Xiao*‡
The metal-binding sites of Ab peptides are dictated primarily by the coordination preferences of the
metal ion. Consequently, Cu(I) is typically bound with two His ligands in a linear mode while Cu(II) forms
a pseudo-square planar stereochemistry with the N-terminal amine nitrogen acting as an anchoring
ligand. Several distinct combinations of other groups can act as co-ligands for Cu(II). A population of
multiple binding modes is possible with the equilibrium position shifting sensitively with solution pH and
the nature of the residues in the N-terminal region. This work examined the Cu(II) chemistry of the Ab16
peptide and several variants that targeted these binding modes. The results are consistent with: (i) at
pH o 7.8, the square planar site in CuII–Ab16 consists primarily of a bidentate ligand provided by the
carboxylate sidechain of Asp1 and the N-terminal amine supported by the imidazole sidechains of two
His residues (designated here as component IA); it is in equilibrium with a less stable component IB in
which the carboxylate ligand is substituted by the Asp1-Ala2 carbonyl oxygen. (ii) Both IA and IB convert
to a common component II (apparent transition pKa B7.8 for IA and B6.5 for IB, respectively) featuring
a tridentate ligand consisting of the N-terminal amine, the Asp1-Ala2 amide and the Ala2-Pro3 carbonyl;
this stereochemistry is stabilized by two five-membered chelate rings. (iii) Component IA is stabilized for
variant Ab16-D1H, components I (both IA and IB) are imposed on Ab16-A2P while the less stable IB is
enforced on Ab16-D1A (which is converted to component II at pH B6.5); (iv) components IA and IB
share two His ligands with Cu(I) and are more reactive in redox catalysis than component II that features
a highly covalent and less reactive amide N ligand. The redox activity of IA is further enhanced for
peptides with a His1 N-terminus that may act as a ligand for either Cu(I) or Cu(II) with lower re-organization
energy required for redox-shuttling. This study provided insights into the determinants that regulate the
reactivity of Cu–Ab complexes.
Significance to metallomics
Copper binding to Ab peptides has been subjected to recent intensive studies due to its possible relevance to the aetiology of Alzheimer’s disease. Multiple
metal binding ligands are present in the soluble and unstructured N-terminal section of Ab(x–16), where x4 1 indicates truncation. The nature of the copper
binding modes is dictated by the coordination preference of the copper oxidation state and by the medium pH, as is the reactivity of the Cu–Ab complexes. This
study clarifies current controversy regarding several important Cu(II) binding modes and provides an improved understanding of the complex copper chemistry
of Ab peptides.
Introduction
Disruption of metal homeostasis has been linked to Alzheimer’s
disease and undesirable interactions between Ab peptides and
copper ions may play roles in the promotion of toxic Ab
aggregation and/or in the catalytic production of reactive oxygen
species (ROS).1,2 Monomeric Ab peptides are flexible and
unstructured and the copper binding sites and binding modes
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change dynamically with the oxidation state and pH,3,4 as does
the reactivity of the metal centres towards ligand substitution
and redox catalysis.5,6
Previous studies have demonstrated that Ab peptides bind
Cu(I) in dynamic linear two-coordinate modes utilizing the
three diﬀerent combinations of the available His-6, -13 and
-14 sidechains (Fig. 1a).7,8 In contrast, they typically bind Cu(II)
in a square planar-based stereochemistry. The N-terminal
amine nitrogen acts as a primary anchoring ligand. Depending
on the conditions, several distinct combinations of other groups can
act as co-ligands. The speciation depends sensitively on themedium
pH and on the nature of the available co-ligands including the
His residues, the sidechain of Asp1 and the carbonyl oxygen or
deprotonated amide nitrogen of the Asp1-Ala2 peptide link
(Fig. 1b).3,4 Note the presence of stabilizing six- or five-membered
chelate rings in each Cu(II) complex.
The three distinct complexes in Fig. 1b are designated as
components IA, IB and II in this work. Notably, they each can
incorporate diﬀerent combinations of His ligands as they appear to
be conformationally available. Structure IA has frequently been
proposed as a coordinationmode at lower pH.9–11 However, recently
IB has been preferred, based mainly on EPR studies.4,12,13
A transition from components IA/B to component II requires
deprotonation of the peptide amide of Ala2 and is promoted by
elevated pH. Any modification or truncation to the N-terminal
residues, as occurs in native Ab peptides,14,15 can alter the Cu(II)
binding modes dramatically. For example, both the substitution
of Asp1 with Asn and deletion of Asp1 to impose Ala2 as the
N-terminal residue in the Ab16 peptide lead to a decrease of over
one pH unit in the pKa of transition I- II.
16–19 Deletion of the
first three residues, as detected in native Ab peptides in high
proportion,14,15 generates a classic N-terminal H2N-X-X-His3
motif known as the ATCUN (amino terminal copper and nickel)
binding motif: the Cu(II) centre is stabilized by three chelate
rings in a tetradentate ligand (Fig. 2b).20–23
The diﬀerent binding modes sensitively aﬀect the reactivity
of Cu–Ab complexes towards ligand substitution and redox
catalysis, especially for Cu(II).5,6,8,16,17 This study undertook a
range of chemical and spectroscopic studies of the copper
chemistry of the Ab16 peptide to provide improved insight into
the relationship between binding mode and reactivity. In
particular, several variants that targeted the Cu(II) binding site
specifically were examined. The work was facilitated by the
recent development of a set of peptide-based fluorescent dansyl
probes DP1–4 that are able to quantify Cu(II) binding stoichiometries
and affinities from micromolar to femtomolar concentrations
on a unified scale.8,21 The combined data demonstrated that (i)
the Ab16 peptide binds Cu(II) dominantly as component IA in
equilibrium with less stable IB at low pH, while at higher pH,
component II predominates (Fig. 1b); (ii) component I is more
reactive than component II in redox catalysis.
Experimental section
Materials and general procedure
Materials purchased from Sigma included the ligands Ferene S
(Fs), Ferrozine (Fz) and bicinchoninic anion (Bca) (as their
sodium salts Na2Fs, NaHFz and Na2Bca), and the reductants
NH2OH (as its H2SO4 salt) and ascorbic acid (Asc). They were all
used as received. A standard Cu(II) solution was prepared by
dissolving CuSO4 inMilli-Q water and the concentration calibrated
via reaction with excess of the Cu(I)-binding ligand Bca in Mops
buﬀer containing reductant NH2OH. Under such conditions, all
copper ions are converted quantitatively to the well-defined
chromophoric complex anion [CuI(Bca)2]
3 with characteristic
absorbance at 562 nm (e = 7900 M1 cm1).24 The peptides and
probes listed in Table 1 were purchased from GL Biochem
(Shanghai) except for Ab16-A2P and Ab16-D1H/H14A which were
synthesized on site by standard solid phase peptide techniques as
Fig. 1 Proposed models of coordination of the Ab peptide to Cu(I) (a) and
Cu(II) (b). Note: only the equatorial ligands are indicated for the Cu(II) sites,
and possible weakly binding axial ligands may include various side-chain
carboxylates or water.
Fig. 2 Proposed equatorial Cu(II) ligands in DP3 and DP4 (see Table 1 for
sequences).21 Possible axial coordination ligand(s) include carboxylate(s)
from Asp4 and/or Asp6 in DP3 and imidazole nitrogen ligand(s) from His1
and/or His4 in DP4. DNS = dansyl fluorophore.
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detailed previously.25 The identity of each peptide was verified by
electrospray ionization mass spectrometry (ESI-MS; Table 1) while
the purity was confirmed to be498% by HPLC. Peptide concentra-
tions were estimated from absorbance maxima atB276 nm using
emax = 1410M
1 cm1 for Ab16 peptides containing a single tyrosine
residue. The concentration of dansyl peptide probes DP2–4 was
estimated by absorbance maxima atB326 nm using the reported
emax = 4500 M
1 cm1 for each probe.21 The concentrations
obtained matched those estimated from fluorescence titrations
with the copper standard assuming the formation of a 1 :1 complex.
All ligand stock solutions, reaction buﬀers, reductant solutions
and protein solutions were prepared in rigorously deoxygenated
Milli-Q water and stored in an anaerobic glove-box (o1 ppm O2).
The working solution of ligand Fs was prepared freshly from
aliquots of frozen stock solution stored in a freezer at temperature
80 1C.26 All reactions involving Cu(I) were performed anaerobically
in the glove-box and transported outside in a capped cuvette for
spectroscopic characterization.
Spectroscopic methods
UV-visible spectra were recorded on a Varian Cary 300 spectro-
photometer in the dual beam mode with quartz cuvettes. All
metal titrations were performed in appropriate buﬀers and
corrected for baseline and dilution. Fluorescence emission
spectra were recorded on a Varian Cary Eclipse spectrophoto-
meter with a band pass of 20 nm for both excitation and
emission. The excitation wavelength for the dansyl peptide
(DP) probes was 330 nm and the emission spectra were recorded
between 450 and 750 nm at a scan rate of 600 nm min1.
Electron paramagnetic resonance (EPR) spectra were recorded
on a Bruker Elexsys E 500 EPR spectrometer under the following
instrument conditions: microwave frequency n = 9.456–9.495 GHz
but conversion to a single frequency of 9.475 GHz for reporting via
relationship g = 714.4775 n/F, where F is the magnetic field in the
Gauss unit, the microwave power is B1 mW, the modulation
amplitude is 4 G, the modulation frequency is 100 kHz, the
sweep time is 40 s, the time constant is 20 ms, and the average
number of scans is 10. All sample solutions (total 0.2 mL) were
prepared in 50 mM buffer (Mes at pH 5.9–6.5; Mops at pH
6.6–8.0 or Ches at pH 4 8) containing [Cu(II)]tot = 0.45 mM,
[peptide or probe]tot = 0.5 mM and 5% glycerol. The solution pH
of each sample was re-checked after recording each spectrum.
The samples were snap-frozen in liquid nitrogen and the
spectra recorded at 77 K in a liquid-nitrogen finger Dewar.
The EPR parameters (g values and A values) were extracted
directly from the recorded spectra without simulation.
Quantification of Cu(II) binding
Cu(II) binding to Ab peptides was quantified with a series of DP
probes as reported recently.21 These probes feature a dansyl
group and emit intense fluorescence at lmax B 550 nm upon
excitation atB330 nm. They bind one equiv. of Cu(II) with varying
aﬃnities and Cu(II) binding to the probes is detected sensitively via
proportional fluorescence quenching. The quantification is based
on the following relationships:
CuIIDP + Ab" CuIIAb + DP (1)
Kex ¼ ½Cu
IIAb½DP
½CuIIDP½Ab ¼
KD Cu
IIDP
 
KD CuIIAbð Þ (2)
½Abtot
½DPtot
¼ ½Cutot  Cu
IIDP
 
½DPtot
þ KD Cu
IIAb
 
KD CuIIDPð Þ
½Cutot
CuIIDP½   1
 
1 Cu
IIDP
 
½DPtot
 
(3)
CuIIDP
 
DP½ tot
¼ F0  F
F0  F1 ¼
DF
DF1
(4)
where KD(Cu
IIAb) and KD(Cu
IIDP) are the respective dissociation
constants under the same conditions. Eqn (3) is derived from
eqn (2) with incorporation of mass balance relationships for an
eﬀective competition described by eqn (1) and is a convenient
format for curve-fitting of the experimental data to derive KD(Cu
IIAb)
with known KD(Cu
IIDP). Under the conditions of the fluorescent
emission of the dansyl probes (lex = 330 nm; lem = 550 nm), the Ab
peptides are fluorescence-silent. Consequently, the Cu(II) speciation
in eqn (1)–(3) may be analysed conveniently and reliably by
monitoring the response of the probe to binding of Cu(II) via eqn (4),
where F0, F and F1 are the fluorescence intensity of the DP probe
upon binding 0, o1.0 and 1.0 equiv. of Cu(II), respectively. The
experiments were performed via reported protocols.21
The KD values for each peptide were determined similarly at
a range of pH values. The pH-dependent aﬃnities of the Cu(II)
probes DP2–4 have been reported recently.21 If the Cu(II) binding
site remains unchanged within a pH range and the ligand
compositions are known, then the conditional KD within that
pH range may be correlated with the absolute dissociation
constant (KabsD ) and the proton ionization constants (Kan) of each
ligand function of the site according to eqn (5):
KD ¼ KabsD 1þ
Xn
i¼1
10
Pn
i¼1
pKaiipH
 0
B@
1
CA (5)
The experiments were conducted in buﬀers (50 mM) Mes
(pH 6.0–6.6), Mops (pH 7.0–7.4), Hepes (pH 7.8–8.2) and Ches
Table 1 Sequences of Ab16 peptides and probesa
Peptide or probe Sequence
Molar mass (Da)
Calcd Found
Ab16 DAEFRHDSGYEVHHQK 1955.0 1954.5
Ac-Ab16 Ac-DAEFRHDSGYEVHHQK 1997.0 1997.5
D1A AAEFRHDSGYEVHHQK 1911.0 1910.7
D1E EAEFRHDSGYEVHHQK 1969.0 1970.4
D1N NAEFRHDSGYEVHHQK 1954.0 1954.9
D1H HAEFRHDSGYEVHHQK 1977.0 1978.0
D1H/H14A HAEFRHDSGYEVHAQK 1911.0 1911.4
A2P DPEFRHDSGYEVHHQK 1981.0 1981.5
DP2 DAE(KDNS)RHDH 1240.3 1240.9
DP3 HP(KDNS)DHDH 1118.2 1118.0
DP4 H(KDNS)HH 790.8 790.4
a The residues changed are underlined in bold.
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(pH 8.5–9.2). On the other hand, the relationship between the
determined KD and pH may also be employed to model the
most likely binding site using eqn (5) to derive KabsD for the Cu(II)
complex and Kan for the possible binding ligands.
Quantification of Cu(I) binding
Competition for Cu(I) with a suitable probe ligand L (L = Fs or
Fz) was set up according to eqn (6) and (7):26
[CuIL2]
3 + Ab" CuIAb + 2L2 (6)
Ab½ tot
CuI½ tot
¼ 1 Cu
IL2
 
CuI½ tot
þ KDb2
L½ tot
CuIL2½   2
 2
CuIL2
 
1 Cu
IL2
 
CuI½ tot
 
(7)
where b2 is the known formation constant for the chromophoric
probe complex [CuIL2]
3 whose equilibrium concentration may be
determined directly from the specific solution absorbance. The
dissociation constant KD for the Cu
I–P complex was determined by
curve-fitting of the experimental data to eqn (7). Probe ligands Fs
and Fz were employed and they bind Cu(I) with different affinities
(logb2 = 13.7 for L = Fs and 15.1 for L = Fz).
26 The experiments were
performed via reported protocols.26
Catalytic aerobic oxidation of ascorbate
Experiments were conducted in air-saturated Mops buﬀers
(50 mM; pH 6.6 and 7.4) and Ches buﬀer (50 mM, pH 8.7).
To minimize the catalytic eﬀect from unbound copper, a stock
solution of each Cu–peptide complex was prepared with one-
fold excess of the corresponding apo-peptide and the total
copper content quantified accurately with the Cu(I) probe Bcs
as a stable chromophoric complex [CuI(Bcs)2]
3 (log b2 = 19.9;
e483 = 13 000 M
1 cm1).27 The reactions were conducted using
a quartz mixing cuvette where one half-cell was loaded with Asc
(B100 mM) and the other half-cell with the CuII–Ab complex
(varying in concentration between 2 and 40 mM, dependent on
the catalytic activity). After recording the background reaction
(if any), the catalytic reaction was started by quick mixing (note:
the concentration of each component in the half-cells becomes
half after the mixing) and followed in real time by the change in
absorbance A265 of the reduced Asc. The oxidation rate was
expressed as mM min1 and calculated using the extinction
coefficient e265 = 14500 M
1 cm1 for Asc.28 The catalytic activity
of each Cu–Ab complex was expressed as molar turn-over num-
ber per min (MTN/min) and was obtained from the slope of a
linear plot of the Asc oxidation rate (mM min1) versus the
concentration (mM) of each Cu–Ab complex. The background
oxidation rate without added Cu has been removed from the
determined oxidation rate.
Formal reduction potential
The formal reduction potential of the copper centres in each
Cu–Ab16 complex was estimated from the relative affinities of
the peptides for Cu(I) and Cu(II) under the same conditions via
the Nernst relationship of eqn (8):
E0
0 ðmVÞ ¼ E0 þ 59 log KD Cu
II
 
KD CuIð Þ
 
(8)
where E0 = 153 mV (vs. SHE) is the standard reduction potential
of Cu2+/Cu+.29
Results and discussion
The N-terminal residues of Ab peptides have a major impact on
Cu(II) binding
Processing of the amyloid precursor protein (APP) by proteases
b- and g-secretase generates the Ab peptides 1–(36–43) whose
interaction with transition metal ions, and with copper, in
particular, appears to be a source of toxicity in vivo.30 The
possible effects include catalytic generation of reactive oxygen
species (ROS) by toxic oligomers.2,31,32 All major Cu ligands are
located within the first 16-residue water-soluble fragment and
thus Ab16 is a valid model for the study of the copper chemistry
of full length Ab.3 In particular, the N-terminal amine nitrogen
and nearby residues play a critical role in Cu(II) coordination
and in imposing both binding affinity and coordination modes.
In this study, the two N-terminal residues Asp1 and Ala2 of
Ab16 were changed systematically via generation of the following
variants (Table 1):
(i) D1A eliminates the sidechain of residue 1 as a potential
ligand (cf. IA of Fig. 1b).
(ii) D1E, D1N, and D1H provide alternative residue 1 side-
chains as potential ligands; D1H/H14A also removes His14 as a
potential ligand.
(iii) A2P removes the amide of residue 2 as a potential anionic
ligand (cf. II of Fig. 1b).
In addition, the N-terminus was acetylated (Ac-Ab16) to
perturb its metal binding properties. Detection of fine diﬀerences
in properties is possible with a set of peptide-based dansyl
fluorescent probes DP2–4 (Tables 1 and 2).21
A control titration of standardized CuSO4 solution with the
DP2 probe alone generated a titration curve with an endpoint at
[Cu(II)]tot/[DP2] = 1.0 (Fig. 3a and b, black trace), confirming
that the probe binds a single Cu(II) ion of the highest aﬃnity
(logKD = 9.9).21 The equivalent titration into a 1 : 1 mixture of
DP2 and Ab16 (2.0 mM) inMops buﬀer (50mM, pH 7.4) generated a
titration curve with an apparent endpoint at [Cu(II)]tot/[DP2]B 2.0
(Fig. 3b, red trace). The essentially linear nature of the curve
indicated that the peptide can bind one equiv. of Cu(II) with
an aﬃnity similar to that of DP2. Indeed, the Cu(II) binding
sequence in the DP2 peptide was designed as a mimic of Ab16
(Table 1).21
Equivalent titrations for Ab16-D1A and Ab16-D1H also displayed
apparent titration endpoints at [Cu(II)]tot/[DP2]B 2.0 (Fig. 3b, green,
blue), consistent with these peptides also binding a single Cu(II)
ion. However, the diﬀerent shapes of the titration curves are
consistent with the aﬃnity of Ab16 being higher than that of
Ab16-D1A but lower than that of Ab16-D1H. In fact, the probe
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does not compete eﬀectively with the latter peptide until
[Cu(II)]tot/[DP2] B 1.
A more quantitative approach is possible with the fluorescence
recovery analysis of titrations of apo-peptides into solutions of a
copper–probe complex of appropriate affinity. Preliminary testing
indicated that the appropriate experiments involved sub-
stoichiometric Cu(II) in the systems CuII0.9–DPx (x = 2 for Ab16-
D1A and 3 for Ab16-D1H and x = 2 or 3 for Ab16). Analysis of the
results suggested that, at pH 7.4, the Cu(II) binding affinity of
Ab16-D1A is 5-fold weaker than that of Ab16 while the affinity of
Ab16-D1H is B100 times stronger (Fig. 3c–f and Table 2).
Equivalent experiments and analyses for the remaining
peptides, with their respective optimal DP probes, lead to an
increasing order of relative Cu(II) binding aﬃnities at pH 7.4 as
follows (Table 2):
Ac-Ab16 (50) o Ab16-D1A (5.0) o Ab16-D1E (3.2)
o Ab16-D1N (2.0) o Ab16 (1.0) B Ab16-A2P (1.0)
o Ab16-D1H/H14A (0.02) o Ab16-D1H (0.01) (9)
The numbers in the brackets refer to the dissociation constants
normalized to that of Ab16 and decrease in the order of increasing
Cu(II) binding aﬃnity. It is apparent that the residues in the
N-terminal region have a major impact on the binding aﬃnity
and likely on the binding mode as well. A more complete
analysis follows.
Component IA is favoured by the presence of a His1-based
chelate ring
The two most significant changes in Cu(II) binding aﬃnity are
seen for Ac-Ab16 and Ab16-D1H (eqn (9)). The N-terminal
amine nitrogen was blocked by acetylation in Ac-Ab16, leading
to a significant decrease in aﬃnity under all conditions (Table 2),
confirming the primary anchoring role of the N-terminal nitrogen
in Cu(II) binding for each of the components IA, IB and II.
Replacement of the carboxylate sidechain of Asp1 with the
imidazole sidechain of His1 in Ab16-D1H led to an increase in
aﬃnity of almost two orders of magnitude at pH 7.4 (Table 2).
Table 2 LogKIID for Cu(II) of Ab16 peptide and variants at diﬀerent pH values
a
Ab16 peptide or DP probe
logKIID K
II
D/K
II
D (wt)
Aﬃnity standardpH 6.2 pH 7.4 pH 9.4 pH 6.2 pH 7.4 pH 9.4
WT 8.1 9.8 12.9 1.00 1.00 1.00 DP2
D1A 7.2 9.1 12.9 7.94 5.01 1.00 DP2
D1E 7.3 9.3 12.9 6.31 3.16 1.00 DP2
D1N 7.9 9.5 12.7 1.58 2.00 1.58 DP2
A2P 8.3 9.8 12.4 0.63 1.00 3.16 DP2
D1H 9.7 11.7 13.3 0.03 0.01 0.40 DP3
D1H/H14A 9.4 11.5 12.8 0.05 0.02 1.26 DP3
Ac-Ab16 ndb 8.1 12.1 ndb 50 6.3 DP2
DP2c 8.1 9.9 12.9 Gly/His
DP3c 9.9 12.2 13.5 Gly/His
a The logKIID values were determined via ligand competition for Cu(II) between each peptide and the specified DP probe ligand in respective buﬀer
(50 mM) of Mes (pH 6.2), Mops (pH 7.4) and Ches (pH 9.4). See the Experimental section for details. b Too weak to be determined reliably.
c Following relationships demonstrated from a previous study21 were used to calculate the logKIID values given in the table: logK
II
D = 1.15–1.49 pH for
DP2 and eqn (5) with KabsD and each pKa value given in Table 3 for DP3.
Fig. 3 Quantification of Cu(II) binding to Ab16 peptides in Mops buﬀer
(50 mM, pH 7.4). (a) Illustrative quenching of the fluorescence spectrum of
a DP2 probe (2.0 mM) upon titration with Cu2+ solution (lex = 330 nm;
lem = 550 nm); (b) Cu
2+ titration curves at 550 nm for 1 : 1 mixtures
(2.0 mM) of DP2 and Ab16 peptides plus control with DP2 only; (c and d)
recovery of the Cu(II)-quenched fluorescence intensity of mixtures (c)
CuII0.9–DP2 or (d) Cu
II
0.9–DP3 (2.0 mM) upon titration with Ab16 peptides;
(e and f) correlation of (e) [CuII–DP2] versus [Ab16 peptide]tot/[DP2]tot or
(f) [CuII–DP3] versus [Ab16 peptide]tot/[DP3]tot. The solid traces in (e and f)
are the fits of eqn (3) to the experimental data, allowing estimation of the
conditional log KIID for the Cu(II) complex of each Ab16 peptide in the range
of pH values listed in Table 1.
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The presence of His1 allows the formation of a stabilizing bidentate
ligand comprising the N-terminal amine and the His1 sidechain
within a six-membered chelate ring. Other known examples of this
binding mode include the DP3 probe employed in this work
(Fig. 2a) and the bacterial copper binding proteins PcoC and
CopC.24,33–35 The Cu(II) coordination sphere in CuII(Ab16-D1H)
may be depicted schematically by Fig. 4a(i), noting its similarity to
the proposed IA site in Ab16 (Fig. 1b). There are three other His
residues (His-6, -13, -14) in the Ab16-D1H sequence, but only two of
them are required to constitute the proposed Cu(II) site. In fact,
replacing one of them (His14) with Ala in Ab16-D1H/H14A only
marginally affects the Cu(II) affinity (Fig. 5a and Table 2).
The Cu(II) sites proposed above for CuII(Ab16-D1H) and
CuII(Ab16-D1H/H14A) are supported by the fact that the
pH-dependence of their aﬃnities for Cu(II) (expressed as
pKIID = –logK
II
D) can be modeled satisfactorily over the pH range
6.0–8.7, assuming that the dependence is driven by the basicity
of the proposed ligands (Fig. 5a and eqn (5)). Their derived
ligand pKa values are listed in Table 3. The I- II transition is
not evident in these peptides and the pH dependence of the
affinities is comparable to those of several documented examples
including DP3 and several CopC proteins that adopt a DP3-type
Cu(II) binding mode, shown in Fig. 2a.21,33
In contrast, the absence of His1 in the WT, D1A and A2P
peptides leads to very diﬀerent pH-dependencies that could not
be modelled over the same pH range with any single set of ligands
or a single binding mode (Fig. 5). The behaviour is attributed to
the influence of the I- II transition, even for the A2P peptide at
pH 4 8.5 (see Fig. 6c). The Cu(II) site of component II features a
deprotonated peptide amide ligand (Fig. 1b).
pH-Dependent EPR spectra provide further support for the
proposed binding models. The EPR signal of CuII(Ab16-D1H)
shows no change within the pH range 5.9–8.9 and essentially
superimposes that of CuII–DP3 (Fig. 6a and b). It differs
significantly from the component I EPR signals of CuII(Ab16)
or CuII(Ab16-A2P) (cf., Fig. 6a–d and Table 4). This supports a Cu(II)
site in CuII(Ab16-D1H) of composition [NH2, 3Nim] that features
the stabilizing bidentate ligand comprising the N-terminal amine
and the His1 sidechain (Fig. 2a and 4a(i)).
This particular His1 sidechain binding mode is suppressed
in CuII–DP4. Although its four-residue peptide sequence (His-Lys-
His-His) features a His1 residue, the presence of His3 provides
the more favourable ATCUN binding mode that includes the
N-terminal amine and two intervening deprotonated backbone
amides (Fig. 2b).21 This conclusion is supported by the dramatic
pH-dependence of its Cu(II) binding affinity and the unique EPR
signal: both are readily distinguishable from those of components
I and II (Fig. 5b and 6f).21 This same ATCUN binding mode is
adopted by the N-truncated Ab16 peptide, Ab4-16 (sequence:
FRHDSGYEVHHQK) that exhibits Cu(II) affinities and EPR spectra
equivalent to those of DP4 (Table 4).16,21–23
Component IB is favoured by an Ala1 N-terminus at low pH but
is less stable than IA
The variant Ab16-D1A has a five-fold lower aﬃnity for Cu(II) than
Ab16 at pH 7.4 (eqn (9); Fig. 5a; Table 2). The I- II transition in
CuII(Ab16) with pKa B 7.8 is characteristic of deprotonation of
the peptide amide of Ala2. The non-coordinating methyl side-
chain of Ala1 eliminates the IA binding mode, enforcing a IB
mode (Fig. 4a(ii)) that is converted to component II at pHB 6.5,
i.e.,4 1 pH unit lower than that for the equivalent transition of
CuII(Ab16) (Fig. 6d and e). However, at higher pH values, the
aﬃnities of Ab16 and Ab16-D1A for Cu(II) become indistinguish-
able (Fig. 5a), consistent with a common tridentate chelate
[–NH2, N
, CO] as part of the square planar array [–NH2, N
,
CO, Nim], characteristic of component II (Fig. 1b). The binding
affinity of the latter shows a different pH dependency and EPR
signal to those of DP4, a Cu(II) ligand of the ATCUN binding
mode (Fig. 2b, 5 and 6).
The equivalent data for variants D1N and D1E provide further
support for a role for Asp1 as an equatorial ligand: their Cu(II)
binding properties are intermediate between those of Ab16 and
Fig. 4 Proposed Cu(II) coordination modes of Ab16 peptides and variants.
(a) Component IA for CuII(Ab16-D1H) and component IB for CuII(Ab16-D1A).
(b) Equilibria between compoments IA, IB and II for CuII(Ab16).
Fig. 5 Variation of conditional pKIID (= logKIID) with solution pH: (a) Cu(II)
complexes of various Ab16 peptides (see Table S1 for the Experimental
data, ESI†); (b) Cu(II) complexes of DP3 and DP4 probe peptides (data
adapted from ref. 21). The dotted traces for peptides D1H, D1H/H14A and
DP3 are the curve-fittings of the respective experimental data to eqn (5)
generating KabsD and pKa for each ligand of the Cu(II) sites that are given in
Table 3. Note: the data for D1H and D1H/H14A above pH 8.7 cannot be
fitted to the model.
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D1A (Table 2 and Fig. S1–S4, ESI†). The data are consistent with
the weaker ligand properties of the sidechains of Asn1 (neutral
carboxamide is a poor ligand for Cu(II)) and Glu1 (which would
form a less favoured seven-membered chelate ring). In particular,
substitution of Asp1 with Asn or Glu also leads to a decrease in
Cu(II) binding affinity (Table 2) and in the pKa for the I - II
transition (Fig. S1 and S4, ESI†).
Several previous studies provide support for this model.
Deletion of Asp1 in Ab16 generates a truncated peptide with
an Ala N-terminus (sequence: AEFRHDSGYEVHHQK). Its qualitative
Cu(II) binding properties are comparable to those of D1A: weaker
binding aﬃnity for Cu(II) and a lower I- II transition pKa.
16 Similar
eﬀects were also observed for D1N,17–19 although the decreased
pKa was attributed to the change of a putative hydrogen bond to
the Cu(II) ligand.17
Component I is favoured in CuII(A2P)
The I- II transition relies on the availability of the Asp1-Ala2
peptide amide (Fig. 1b). Substitution of Ala2 with Pro eliminates
this possibility and all properties observed for CuII(A2P) are
consistent with the binding mode being locked in component I.
Most obviously, KD is comparable to that of Cu
II(Ab16) at lower
pH values but becomes larger (i.e., lower aﬃnity) at higher pH
with the point of deviation occurring above pH 7.8, in line with
the I - II transition for CuII(Ab16) around this pH (Fig. 5a
and 6d). The EPR signal confirmed that component I of
CuII(Ab16-A2P) was present up to at least pH 8.5 (Fig. 6c).
At lower pH, component IA is preferred for Ab peptides with an
Asp1 N-terminus
The Cu(II) aﬃnities of component I of CuII(Ab16) and CuII(Ab16-
A2P) are similar. They are about one order of magnitude higher
than that of component IB, which is favoured for CuII(Ab16-
D1A) at lower pH values such as pH 6.2 (Fig. 5a and Table S1,
ESI†). This implies that component IA rather than IB is the
preferred binding mode for both CuII(Ab16) and CuII(Ab16-A2P)
at lower pH values (Fig. 1b). This is consistent with the
Table 3 Thermodynamic data of Cu(II) sites derived from correlation of logKD and pH
a
Peptide or protein Cu(II) binding site LogKabsD
pKa for
Ref.NH2 N
Im
Ab16-D1H NH2 (H1); 3 N
Im (H1,6,13/14) 12.7 8.3 6.4 This work
Ab16-D1H/H14A NH2 (H1); 3 N
Im (H1,6,13) 12.3 8.1 6.4 This work
DP3 probe NH2 (H1), 3 N
Im (H1,5,7) 13.6 8.8 6.5 21
Pf-CopC NH2 (H1); 3 N
Im (H1,3,85) 17.2 8.8 6.6 33
Ps-CopC NH2 (H1); 2 N
Im (H1,91); COO (D89) 14.4 8.2 6.1 33
Ec-PcoC NH2 (H1); 2 N
Im (H1,92); COO (D90) 14.0 8.2 6.5 33
a See Fig. 5 for experiments; parameters obtained by curve-fitting to eqn (5).
Fig. 6 Frozen solution EPR spectra of various Cu(II) complexes recorded
at 77 K. The Cu(II) ligands are: (a) DP3 probe; (b) Ab16-D1H; (c) Ab16-A2P;
(d) Ab16; (e) Ab16-D1A; (f) DP4 probe at various pH values as indicated (see
the Experimental section for detail). Insets show enlargements of the
spectra scaled up by a factor of 3. Component I is indicated by green
dashed lines and component II by red dashed lines.
Table 4 EPR parameters derived from frozen solution spectraa
Ligand for the
CuII complex
Component I Component II
pKa for
I2 IIgJ g> AJ (G) gJ g> AJ (G)
DP3 2.242b 2.060b 182b — — — —
Ab16-D1Hc 2.243 2.060 183 — — — —
Ab16-A2P 2.269 2.051 169 — — — B8.8
Ab16 2.268 2.050 170 2.202 2.042 160 B7.8
Ab16-D1A 2.269 2.051 169 2.204 2.041 161 B6.5
Ab2-16 2.264d,e — 170d,e 2.226d — 153d —
DP4 — — — 2.178b 2.050b 200b —
Ab4-16 — — — 2.178d 2.049d 206d —
a Estimated directly from the respective spectrum, see Fig. 6, Fig. S1–S7
(ESI) for details. b Data adopted from ref. 21. c Data for CuII(Ab16-D1H/
H14A) were indistinguishable (see Fig. S5 and S6, ESI). d Data adopted
from ref. 16. e Minor component at pH 7.4.
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negatively charged harder carboxylato ligand favouring the
harder metal ion Cu(II) over a neutral peptide carbonyl oxygen
for similar stereochemistries (a six-membered chelate ring in IA
versus a five-membered chelate ring in IB; see Fig. 1b).
However, the possibility for a IB binding mode for either
CuII(Ab16) or CuII(Ab16-A2P) at low pH cannot be excluded. The
EPR signals for both components IA and IB are indistinguish-
able (Fig. 6c–e and Table 4) and cannot be used to differentiate
the binding modes at low pH. It is possible that components IA
and IB are in fast exchange at lower pH for those peptides with
an Asp1 N-terminus but with IA being the preferred binding
mode. At higher pH, both components IA and IB are converted to
component II: the KD values of Cu
II(Ab16) and CuII(Ab16-D1A)
become indistinguishable at pH 9.4 (Fig. 5a). But the I - II
conversion is restricted for CuII(Ab16-A2P), weakening its Cu(II)
binding affinity at high pH relative to other Ab16 peptides
(Fig. 5a).
It is unlikely that the diﬀerences in the properties of CuII(Ab16),
CuII(Ab16-A2P) and CuII(Ab16-D1A) at lower pH values are due
to axial coordination by the Asp1 sidechain due to the following
reasons:
(i) Given the possibility of axial coordination, mutation of
Asp1 by Ala should lower the aﬃnity across the whole pH range.
However, there is no diﬀerence in the Cu(II) aﬃnity for component II
between WT and D1A.
(ii) A bidentate [NH2, COO
] binding mode for peptides with
N-terminal aspartyl residues has been well-documented in
many cases, including various Ab peptides.11,36,37
(iii) The IA binding mode is confirmed for many peptides
and proteins with a His1 N-terminus including Ab16-D1H, DP3
probe, CopC and PcoC proteins, as surveyed above.
(iv) Contributions from axial coordination at Cu(II) centres
are usually negligible due to the Jahn–Teller effect. There are
many possible carboxylate sidechains (Asp1, Asp7, Glu3 or
Glu11) which have been proven to be redundant. For example, an
E3Q mutation showed no significant effect on the EPR spectrum.3
The IA coordination mode for Ab16 has been proposed
frequently as one of the two possible coordination modes of
Asp1 at lower pH for component I (Fig. 1b).9–11 However, component
IB has been preferred recently, based mainly on pulsed EPR
studies.4,12,13 The chemical and spectroscopic study presented
in this work, supported by previous Cu(II) binding studies for
those peptides with N-terminal aspartyl residues,11,36 provides
strong evidence that the preferred binding mode for component
I in CuII(Ab16) is IA, and not IB (Fig. 1b). It is recommended that
the possibility of the IB binding mode can be re-investigated by
pulsed EPR using CuII(Ab16-D1H) and CuII(Ab16-D1A) as controls.
Impact of N-terminal modification on Cu(I) binding
The first evidence of Cu(I) binding to Ab peptides was implicated
in an early study of Cu(II) potentiation of Ab neurotoxicity.38 We
now know that Ab peptides bind Cu(I) mainly via a combination
of two histidine residues within the first 16 residues.7,8 The Cu(I)
binding stoichiometries and aﬃnities of various Ab16 peptides
generated in this work were examined using Cu(I) probe ligands
Ferene S (Fs) and Ferrozine (Fz) according to a recent protocol.26
Both probe ligands react with Cu(I) under reducing conditions
to yield respective chromophoric Cu(I) complexes [CuIL2]
3 with
diﬀerent formation constants (logb2 = 13.7 for L = Fs and
15.1 for L = Fz).26 They were used to estimate the binding
stoichiometries of Ab16 peptides according to eqn (6) under
weakly competing conditions and the binding aﬃnities according
to eqn (6) and (7) under strongly competing conditions. As
demonstrated previously for Ab16,8 most peptides listed in
Table 1 bind a single equiv. of Cu(I) under Cu+ limiting
conditions imposed by a slight excess of the weak probe ligand
Fs (Fig. 7a). The exception was Ab16-D1H that appeared to bind
more than one equiv. Cu(I) under the same conditions (Fig. 7b).
Increasing Fs ligand concentration or employing the stronger
ligand Fz created more eﬀective competing conditions for
eqn (6) that allowed analysis and definition of Cu(I) binding
aﬃnity of each peptide with eqn (7) (Fig. 7c and d). There are
only marginal diﬀerences in Cu(I) binding aﬃnities for those
peptide variants with substitution of a non-His residue in the
sequence. But, the Cu(I) binding aﬃnities of Ab16-D1H and
Ab16-D1H/H14A are slightly higher than those of the other
peptides (Table 5).
The data are consistent with previous observations: (i) the
non-His residues in the N-terminal region play little role in
Cu(I) binding;8 (ii) two and only two His ligands are required for
the flexible Ab16 peptides to constitute a Cu(I) binding site
(Fig. 1a);7,8,39–41 (iii) the Cu(I) bound by Ab16 peptides is
Fig. 7 Change in [CuI(Fs)2]
3 concentration in Mops buﬀer (50 mM,
pH 7.4, 1.0 mM NH2OH) with increasing concentration of apo-peptide Ab16
(a and c) or Ab16-D1H (b and d) under weak competing conditions for
(a and b) ([Cu]tot = 32.5 mM; [Fs]tot = 70 mM) or strong competing conditions
for (c and d) ([Cu]tot = 38.0 mM; [Fs]tot = 140 mM). The dashed lines in
(a and b) suggest Cu(I) binding stoichiometry under weak competing
conditions; the solid traces in (c and d) are the curve-fitting of the
experimental data to eqn (7), allowing estimation of the Cu(I) binding
aﬃnity for each peptide (Table 5).
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populated between different pairs of His ligands in a fast
exchange mode that tends to increase the apparent binding
affinities.7,8 There are three different combinations of His pairs
for most peptides examined in this work (Fig. 1a) and little
difference in their Cu(I) binding properties, except that for
Ab16-D1H/H14A is slightly higher (Table 5).
Ab16-D1H contains an extra His1 residue to provide four
possible His ligands. Its Cu(I) aﬃnity is the highest of all the
peptides. Theoretically, it may bind two equiv. of Cu(I) with
similar aﬃnities, but this does not seem to be the case (Fig. 7b).
Binding of the first equiv. of Cu(I) appears to discourage the
binding of a second equiv. of Cu(I) with the same aﬃnity
(Fig. 7b). Certainly, the first equiv. of Cu(I) bound in Ab16-D1H
may be populated among six diﬀerent combinations of His pairs
with considerable entropic gain, but binding of a further equiv. of
Cu(I) is expected to restrict the binding sites to two His pairs only
with considerable entropic loss.
Impact of the N-terminal modifications on the catalytic aerobic
oxidation of ascorbate
A common feature in Alzheimer’s disease is oxidative stress, a
component of which may result from undesirable catalytic
reduction of dioxygen by cellular reductants such as ascorbate
(Asc) mediated by Cu complexes of Ab peptides.2,31,32,38,46–48
The dioxygen reduction product H2O2 is liable to undergo
further reduction via Fenton-type reactions to generate the hydroxyl
radical that can cause damage not only to the direct copper
ligands,49 but also to the surrounding residues.50 Indeed, Asc is
abundant in the brain as an important neuromodulator and/or a
neuroprotective agent and its concentration fluctuates dynamically
in the range 200–400 mM in certain synaptic clefts.51,52 In reality, the
oxidation rate of Asc by dioxygen is slow and must be catalysed by
redox-active couples such as Cu(II)/Cu(I). It has been proposed that
metal dyshomeostasis in the Alzheimer brain may result in binding
of copper to Ab peptides to initiate catalytic roles.53
Ab peptides can bind Cu(II) with the distinct binding modes
of components I (including IA and IB) and II at physiological
pH (Fig. 1b). Recent studies suggest that the diﬀerent components
available in Cu–Ab16 systems (Fig. 1) display different reaction
kinetics in both metal substitution and redox chemistry.5,6 This
study has identified the critical role of the first two N-terminal
residues in determining these Cu(II) binding modes and an
integrated study of the thermodynamic and kinetic contributions
of these binding modes in the generation of H2O2 via catalytic
aerobic oxidation of Asc was also undertaken. It should be noted
that the reaction scheme in Fig. 8a is presented as an overall two-
electron reaction process, but it may proceed via two consecutive
one-electron steps with O2
 as an immediate reduction inter-
mediate that may be reduced further to H2O2 by a second Cu
I–Ab
complex.54
The experiments were performed in air-saturated buﬀers
(50 mM) at three diﬀerent pH values (Mops buﬀer at pH 6.6 and
7.4; Ches buﬀer at pH 8.7). The catalytic aerobic oxidation of
Asc (50 mM) was undertaken with each Cu–Ab16 complex
(prepared with a one-fold excess of apo-peptide) at a range of
concentrations (1.0–20 mM). The reaction was followed by the
rate of decrease in absorbance at 265 nm for the reduced form
of Asc (Fig. 8a). The catalytic activity of each Cu–Ab16 peptide
complex was determined from the slope of a linear correlation
Table 5 LogKID for Cu(I) of Ab16 peptide variants at diﬀerent pH values
a
Ab16 peptide
logKID K
I
D/K
I
D (wt)
Probe-aﬃnity stdpH 6.2 pH 7.4 pH 9.4 pH 6.2 pH 7.4 pH 9.4
WT 9.6 10.6 11.0 1.00 1.00 1.00 Fs
D1A 9.3 10.6 11.0 2.00 1.00 1.00 Fs
D1E 9.5 10.4 10.9 1.26 1.58 1.26 Fs
D1N 9.5 10.4 10.8 1.26 1.58 1.58 Fs
A2P 9.9 10.7 11.0 0.50 0.79 1.00 Fs
D1H 10.2 11.1 11.5 0.25 0.32 0.32 Fz
D1H/H14A 10.1 10.9 11.3 0.32 0.50 0.50 Fs/Fz
Ac-Ab16 10.4 1.58 Fs
a The logKID values were determined via ligand competition for Cu(I) between each peptide and the specified probe ligands Fs and/or Fz in the
respective buﬀers (50 mM) Mes (pH 6.2), Mops (pH 7.4) and Ches (pH 9.4). See the Experimental section for details.
Fig. 8 (a) Catalytic aerobic oxidation of Asc monitored via A(265). Inset:
Overall catalytic scheme. (b and c) Oxidation rate (mM min1) catalyzed by
various Cu–Ab16 peptide complexes (1–20 mM) in the presence of one-
fold excess of each respective apo-peptide in air-saturated buffers: (b)
Mops buffer (50 mM, pH 6.6); (c) Mops buffer (50 mM, pH 7.4); (d) Ches
buffer (50 mM, pH 8.7). The background oxidation rate (if any) that was
detected in the presence of various concentrations of respective apo-
peptides without added Cu has been removed from the determined rate.
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of the initial oxidation rates versus the catalyst concentrations
and expressed as mM Asc oxidized/mM catalyst per minute, i.e.,
molar turnover number min1 (see the Experimental section
for details).
As observed previously,8,55 Asc is stable in metal-free air-
saturated buﬀers within the experiment timescale (1–2 h) and
all apo-peptides are inactive (at least after demetallation with
EDTA). ‘Free’ Cu2+ and Cu+ have robust catalytic activities that
are suppressed, but not silenced, by apo-peptides. The Cu–Ab16
complexes are redox-active catalysts, but less active than ‘free’
copper. A one-fold excess of apo-peptide over each Cu–peptide
was sufficient to minimize the catalytic contribution from ‘free’
Cu and to allow reliable detection of the catalytic activity of the
Cu–complex. The results are summarized in Fig. 8, Fig. S8 (ESI†)
and Table 6.
At pH 7.4, the molar catalytic activities (min1) of the diﬀerent
Cu–Ab16 complexes for Asc oxidation are given below in increasing
order of their activity:
D1A (0.08 min1) B D1E (0.10) B D1N (0.14) o wt (0.38)
o A2P (0.66) o D1H (0.78) B D1H/H14A (0.9)
(10)
As discussed above, the binding modes and aﬃnities of these
peptides are similar for Cu(I) (with minor diﬀerence for
Ab16-D1H and Ab16-D1H/H14A) but diﬀer considerably for Cu(II).
On the one hand, replacement of Asp1 with Ala, Glu or Asn leads
to destabilization of component IA inducing the I- II transition
at lower pH (Table 4 and Fig. 6). On the other hand, substitution
of Ala2 with Pro suppresses the transition while substitution of
Asp1 by His1 further stabilizes the IA mode (Fig. 4a(i)). The
observed reactivity order of eqn (10) clearly indicates that Cu
sites accommodating a component I type Cu centre possess
higher redox catalytic activity than those adopting a component
II binding mode only. The conclusion applies to both pH 6.6
and 8.7 (Table 6; Fig. 8 and Fig. S8, ESI†).
However, contradictions to these conclusions can be seen in
Table 6. For example, while components IA and II dominate at
pH 6.6 and 8.7, respectively, for CuII(Ab16), they are both
present in equilibrium at pH 7.4 (Fig. 6d and Fig. S1, ESI†),
but the observed activities at pH 7.4 and 8.7 were essentially
identical (Table 6). The complications arise from the fact that
Asc is more stable towards oxidation at lower pH and less stable
at higher pH values. Hence, there are two opposing eﬀects acting
on the Asc oxidation rates: (i) a transition from component I at
lower pH to component II at higher pH decreases the catalytic
rate; (ii) deprotonation of Asc that occurs at higher pH increases
its oxidation rate. This latter eﬀect is seen clearly for Cu(Ab16-
A2P), Cu(Ab16-D1H) and Cu(Ab16-D1H/H14A). Within the pH
range 6–9, component IA dominates in the first complex and is
locked in place in the latter two complexes (Fig. 6b and c).
However, the catalytic oxidation rate increased with pH for each
complex.
To separate these two opposing eﬀects, the observed oxidation
rates were normalized to that of Cu(Ab16-D1H) under the same
conditions (Table 6). The normalized data indicate: (i) the redox
activities of Ab16 and variants Ab16-D1A, -D1E and -D1N decrease
uniformly with increasing pH, consistent with the influence of
the I- II transition (Fig. 6d, e and Fig. S1–S4, ESI†); (ii) the redox
activity of Cu(Ab16-A2P) is lowest at pH 8.7, consistent with a
partial transition of the Cu(II) centre in this complex from
component I to other unknown Cu(II) centre(s) (Fig. 6c) at high
pH; (iii) the redox activities of the two Cu complexes with a His1
N-terminus are higher than all others and notably, the one with
peptide Ab16-D1H/H14A has the highest activity consistently at
all pH values (Table 6). This high redox activity is attributed to a
combined redox advantage of the Cu centres in both oxidation
states and this is further analysed and discussed below.
Determinants that regulate the redox activity of Cu–Ab peptides
In order to be an eﬃcient redox catalytic centre for a particular
process of oxidation and reduction, the formal reduction
Table 6 Aerobic oxidation rate of ascorbate catalyzed by various Cu–Ab16 complexes and calculated thermodynamic reduction potentialsa
Ab16 peptide
Catalytic rate as molar
velocity (min1) at pH
Relative to that with
Cu–D1H as catalyst at pH
E0
0
calc (mV vs. SHE)
at pHb
E00 (mV vs. SHE)
reported at pHc
6.6 7.4 8.7 6.6 7.4 8.7 6.2 7.4 9.4 B6.5 7.4 B8.5
Ab16 0.28 0.38 0.37 0.40 0.49 0.14 +242 +200 +40.9 +2555 +9042 1535
+28043 +1807 Lowc
+30044 +27745
D1A 0.09 0.08 0.17 0.13 0.10 0.06 +277 +242 +40.9
D1E 0.09 0.10 0.12 0.14 0.13 0.04 +283 +218 +35.0
D1N 0.15 0.14 0.15 0.22 0.17 0.06 +247 +206 +40.9
A2P 0.32 0.66 1.12 0.46 0.84 0.42 +247 +206 +70.4
D1H 0.69 0.78 2.70 1.00 1.00 1.00 +183 +118 +46.8
D1H/H14A 0.79 0.90 3.29 1.16 1.15 1.22 +194 +118 +64.5
Ac-Ab16 +277 +2835 1305
a Conditions: [Asc]tot = 50 mM; [Cu–peptide]tot = 1–20 mM with a one-fold excess apo-peptide; buffers (50 mM) of Mops (pH 6.6 and 7.4) and Ches
(pH 8.7). The background oxidation rate without the added Cu has been removed, see the Experimental section for details. b Calculated from
eqn (8) using E0 = +153 mV for the redox couple Cu2+/Cu+ (note: the Cu(I) KD values at pH 6.6 and 8.7 were not determined and thus the calculations
used data at pH 6.2 and 9.4 instead). c Determined by cyclic voltammetry, except a recent theoretical calculation predicted +280 mV for component
I and –370 to –810 mV for component II.43
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potential of the copper centre must be lower than that of
the oxidant but higher than that of the reductant. At pH 7.4,
the formal reduction potentials of ascorbate and dioxygen are
B+50 mV56 and B+300 mV57 (vs. SHE), respectively.
The formal reduction potentials of the Cu–Ab complexes
may be estimated via the Nernst relationship of eqn (8) from
the respective Cu(I) and Cu(II) affinities of each Ab16 peptide
(Table 6). The reduction potentials are generally more negative
for component II than for component I and decrease with increased
pH. This is consistent with the more dramatic stabilization
effect for Cu(II) coordination at higher pH, especially with the
dominant coordination effect of the deprotonated amide nitrogen
to the Cu(II) centre in component II.5,43 The calculated reduction
potentials in this work from the respective dissociation constants
generally match those determined experimentally by cyclic voltam-
metry or predicted from theoretical calculations (Table 6).
However, it must be noted that the dissociation constants of
the Cu–Ab complexes are quite large (indicating relatively weak
binding). In addition, the estimated values vary considerably
with experimental conditions, as do the reduction potentials
determined by cyclic voltammetry (Table 6). The redox processes
are frequently not well-defined due to the different coordination
environments for Cu(I) and Cu(II). Consequently, it is difficult to
define the reduction potentials consistently and accurately as
can be seen from the data in Table 6. Nevertheless, the statistical
data seen there at pH 7.4 suggest that the reduction potentials of
most Cu–Ab complexes studied in this work fall within the
potential window for catalytic oxidation of ascorbate by dioxygen
(Table 6) and therefore should have no significant thermodynamic
impact on their efficiency as catalysts for the aerial oxidation of
ascorbate. In fact, there is no clear correlation between the
calculated reduction potentials and the observed catalytic rates
at the three pH values tested (Table 6).
It is apparent that the diﬀerence in the redox activity of the
Cu centre in each Ab16 peptide must be attributed primarily to
diﬀerences in reaction kinetics that are closely related to the
binding modes for both Cu(I) and Cu(II). As an eﬃcient catalytic
centre, the metal ion must be able to shuttle between diﬀerent
oxidation states with minimal reorganization energy,44 but this
condition is often not met for Cu that prefers diﬀerent ligands
and binding modes for its two biologically accessible oxidation
states. Blue copper proteins such as plastocyanin and azurin
that accommodate robust redox active Cu centres feature con-
formational rigidity in the protein structures that impose an
‘entatic state’ to the Cu centre for eﬃcient electron transfer.58
Such ‘entatic states’ for Ab peptides, however, are problematic,
given their flexibility and unstructured nature. The coordination
spheres for Ab peptides are decided primarily by the coordination
preferences of each oxidation state of the Cu centre, as demon-
strated above and in previous studies.3,8 Consequently, the Cu
centres in Ab peptides are generally not eﬃcient redox catalysts
since only a very small fraction of Cu centres in equilibrium are
pre-organized for electron transfer44 and the catalytic activity of
‘free’ Cu is inhibited upon binding to Ab peptides.8,55,59
At physiological pH, Ab16 binds one equiv. of Cu(I) or Cu(II)
with sub-nanomolar aﬃnities (Fig. 1). Component I in the Cu(II)
system is more reactive in the catalytic oxidation of Asc than
component II for several reasons: (i) component I shares two
His ligands with each of the three possible Cu(I) sites while
component II contains only one His ligand; (ii) the main Cu(II)
ligands for component I are flexible amino acid sidechains
while the dominant Cu(II) ligands for component II are derived
from the peptide backbone with rigid fused chelate rings; (iii) a
Cu–N bond arising from coordination to a negatively charged
amide N is highly covalent and any reactions involving such a
chemical bond are usually slow.6,21,33,43 Consequently, component
I is more reactive than component II, not only in redox catalysis
but also in ligand substitution.5,6 These conclusions are con-
solidated by the observed reactivity orders for related peptides in
ligand substitution6,21,33 and redox turnover (Table 6, eqn (10)).5
In particular, substitution of Asp1 with His1 not only locks
the Cu(II) binding mode to the IA component within the
pH range 6–9 (Fig. 4a(i) and 6b), but introduces a new Cu(I)
ligand in the N-terminus to be shared with the Cu(II) binding
site. This leads to a considerable increase in the redox reactivity
of the Cu centre. Interestingly, removal of the extra non-N-terminal
ligand His14 from Ab16-D1H leads to a further increase in redox
activity (Table 6), presumably attributable to the increased similarity
between the binding sites for both Cu(I) and Cu(II) in the Ab16-
D1H/H14A peptide.
Summary and concluding remarks
Monomeric Ab peptides are flexible and unstructured. Both
metal binding ligands and binding modes change dynamically
with the Cu oxidation state and with reaction conditions. A
range of chemical and spectroscopic studies were carried out
on copper complexes of several Ab16 peptides in which the two
key residues for Cu(II) binding in the N-terminal region were
varied. Key conclusions are as follows:
(i) At lower pH, the Ab16 peptide binds Cu(II) predominantly
as component IA in equilibrium with less stable component IB;
at higher pH, these are converted to component II with transition
pKa B 7.8 (Fig. 1b and 4b);
(ii) Component I sites involve flexible amino acid sidechains
common to the Cu(I) binding ligands, but the metal sites for
component II are dictated by a deprotonated backbone amide
nitrogen that cannot act as a Cu(I) ligand and is slow to
dissociate.5,6,43 Consequently, component I is more reactive than
component II in both metal substitution and redox catalysis.
(iii) Substitution of Asp1 with His provides an extra imidazole
ligand for Cu(I) and also allows the N-terminal His1 to be part of a
stable six-membered chelate ring for Cu(II) coordination.
Consequently, the Cu(II) centre in Ab16-D1H is locked into
component IA with a dramatic increase in its redox activity.
(iv) Replacement of Ala2 with Pro suppresses component II
relative to component I and increases the reactivity of the bound
copper.
(v) Substitution of Asp1 with Ala restricts component I to the
less stable IB form that is readily converted to component II at
physiological pH with decreased catalytic reactivity.
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This study provides insights into determinants that regulate the
reactivity of copper toward Ab peptides andmay guide development
towards a better understanding of the factors contributing to
oxidative stress present within Alzheimer’s disease.
Abbreviations
Asc Ascorbate
Bca Bicinchoninic anion
Bcs Bathocupro¨ine disulfonate
Ches N-Cyclohexyl-2-aminoethanesulfonic acid
DP2 Dansyl peptide 2 (DAE(KDNS)RHDH)
DP3 Dansyl peptide 3 (HP(KDNS)DHDH)
DP4 Dansyl peptide 4 (H(KDNS)HH)
eqn Equation
equiv. Equivalent
ESI-MS Electrospray ionization mass spectrometry
Fs Ferene S
Fz Ferrozine
Hepes 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
His Histidine
Mes 2-(N-Morpholino)ethanesulfonic acid
Mops 3-(N-Morpholino)propanesulfonic acid
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